Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-09

Clinical Trial Update: Biological Standardization of Secale Cereale Allergen Extract [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating the biological standardization of Secale cereale allergen extract for grass pollen allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Secale Cereale Allergen Extract (Secale cereale allergen extract)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Allergy to Grass Pollen (Secale Cereale) | Phase 2 | Status: COMPLETED